Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Dentistry
Volume 2014, Article ID 792615, 4 pages
http://dx.doi.org/10.1155/2014/792615
Case Report

CTCFL (BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity

1Laboratory of Molecular Stomatology, Faculty of Dentistry, Universidad Juárez de Estado de Durango, Predio Canoas Street, 34067 Durango, Mexico
2Department of Molecular Medicine, Faculty of Medicine and Nutrition, Universidad Juárez de Estado del Durango, Universidad Avenue, 34000 Durango, Mexico
3Laboratory of Pathology and Bucal Medicine, Faculty of Dentistry, Universidad Juárez del Estado de Durango, Predio Canoas Street, 34067 Durango, Mexico
4Faculty of Dentistry, Universidad Autónoma de Zacatecas, Begonias Street, Guadalupe, 98600 Zacatecas, Mexico

Received 1 May 2014; Accepted 23 June 2014; Published 10 July 2014

Academic Editor: Tommaso Lombardi

Copyright © 2014 Graciela Zambrano-Galván et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. V. Chaparro-Avendaño, L. Berini-Aytés, and C. Gay-Escoda, “Peripheral giant cell granuloma. A report of five cases and review of the literature.,” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 10, no. 1, pp. 53–67, 2005. View at Google Scholar · View at Scopus
  2. V. K. Adlakha, P. Chandna, U. Rehani, V. Rana, and P. Malik, “Peripheral giant cell granuloma,” Journal of Indian Society of Pedodontics and Preventive Dentistry, vol. 28, no. 4, pp. 293–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Bonetti, G. Pelosi, G. Martignoni et al., “Peripheral giant cell granuloma: evidence for osteoclastic differentiation,” Oral Surgery Oral Medicine and Oral Pathology, vol. 70, no. 4, pp. 471–475, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Lim and J. R. Gibbins, “Immunohistochemical and ultrastructural evidence of a modified microvasculature in the giant cell granuloma of the jaws,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and, vol. 79, no. 2, pp. 190–198, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. R. Carvalho, A. M. Loyola, R. S. Gomez, and V. C. Araújo, “Peripheral giant cell granuloma. An immunohistochemical and ultrastructural study.,” Oral Diseases, vol. 1, no. 1, pp. 20–25, 1995. View at Google Scholar · View at Scopus
  6. P. N. Tandon, S. K. Gupta, D. S. Gupta, S. K. Jurel, and A. Saraswat, “Peripheral giant cell granuloma,” Contemporary Clinical Dentistry, vol. 3, no. 1, pp. 118–121, 2012. View at Google Scholar
  7. J. M. Gándara, J. L. Pacheco, P. Gándara et al., “Granuloma periférico de células gigantes. Revisión de 13 casos clínicos,” Medicina Oral, vol. 7, no. 4, pp. 254–259, 2002. View at Google Scholar
  8. J. E. Phillips and V. G. Corces, “CTCF: master weaver of the genome,” Cell, vol. 137, no. 7, pp. 1194–1211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. J. Rasko, E. M. Klenova, J. Leon et al., “Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF,” Cancer Research, vol. 61, no. 16, pp. 6002–6007, 2001. View at Google Scholar · View at Scopus
  10. G. N. Filippova, C. F. Qi, J. E. Ulmer et al., “Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter its DNA-binding specificity,” Cancer Research, vol. 62, no. 1, pp. 48–52, 2002. View at Google Scholar · View at Scopus
  11. D. I. Loukinov, E. Pugacheva, S. Vatolin et al., “BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 10, pp. 6806–6811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. Klenova, H. C. Morse 3rd., R. Ohlsson, and V. V. Lobanenkov, “The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer,” Seminars in Cancer Biology, vol. 12, no. 5, pp. 399–414, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. Link, W. Zhang, K. Odunsi, and A. R. Karpf, “BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer,” Cancer Immunity, vol. 13, no. 6, pp. 1–9, 2013. View at Google Scholar · View at Scopus
  14. I. Martin-Kleiner, “BORIS in human cancers: a review,” European Journal of Cancer, vol. 48, no. 6, pp. 929–935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Tiffen, C. G. Bailey, A. D. Marshall et al., “The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells,” International Journal of Cancer, vol. 133, no. 7, pp. 1603–1613, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. de Necochea-Campion, A. Ghochikyan, S. F. Josephs et al., “Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome,” Journal of Translational Medicine, vol. 9, no. 1, article 213, 2011. View at Publisher · View at Google Scholar · View at Scopus